A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates

被引:57
作者
ZollaPazner, S [1 ]
Sharpe, S [1 ]
机构
[1] NYU,MED CTR,NEW YORK,NY 10016
关键词
D O I
10.1089/aid.1995.11.1449
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The sensitivity with which antibody-mediated neutralization is-detected in vitro is dependent on the virus, the antibody, the target cells, and the culture conditions used in the assay, Using activated and transformed target cells, the ability of various culture-adapted and primary strains of HIV-1 to be neutralized by different polyclonal and monoclonal antibody preparations has been thoroughly studied, However, the vast majority of HIV-1-susceptible CD4(+) cells in vivo are not activated or transformed, but are quiescent, Because resting lymphocytes can be infected with HIV-1, we initiated studies to determine (1) if the use of resting lymphocytes as target cells would result in a neutralization assay with increased sensitivity, (2) if the degree of target cell activation had a measurable effect on the sensitivity with which antibody-mediated neutralization could be detected, and (3) whether, using a more sensitive assay, neutralizing antibodies in patients' sera might be detectable that had been below the threshold of detection when using ''conventional'' assays, The experiments described in the studies below reveal that an inverse relationship exists between the level of target cell activation and the sensitivity with which neutralization can be detected, Moreover, using an assay in which unstimulated peripheral blood mononuclear cells serve as target cells, experiments show that antibody-mediated neutralization of primary and prototype laboratory isolates of HIV-1 can be detected with 10- to 100-fold greater sensitivity than when stimulated peripheral blood mononuclear cells are used as target cells, With this resting cell assay, neutralizing activity can be detected in the sera of HIV-positive subjects that, by previously used ''conventional'' neutralization assays, was undetectable.
引用
收藏
页码:1449 / 1458
页数:10
相关论文
共 51 条
[11]   A SIMPLE AND RELIABLE METHOD TO DETECT CELL-MEMBRANE PROTEINS ON INFECTIOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES [J].
CAPOBIANCHI, MR ;
FAIS, S ;
CASTILLETTI, C ;
GENTILE, R ;
AMEGLIO, F ;
DIANZANI, F .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) :886-889
[12]   NEUTRALIZATION OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES BY THE BROADLY REACTIVE ANTI-V3 MONOCLONAL-ANTIBODY, 447-52D [J].
CONLEY, AJ ;
GORNY, MK ;
KESSLER, JA ;
BOOTS, LJ ;
OSSORIOCASTRO, M ;
KOENIG, S ;
LINEBERGER, DW ;
EMINI, EA ;
WILLIAMS, C ;
ZOLLAPAZNER, S .
JOURNAL OF VIROLOGY, 1994, 68 (11) :6994-7000
[13]   HIGH-CONCENTRATIONS OF RECOMBINANT SOLUBLE CD4 ARE REQUIRED TO NEUTRALIZE PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES [J].
DAAR, ES ;
LI, XL ;
MOUDGIL, T ;
HO, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6574-6578
[14]  
DIMMOCK NJ, 1993, CURR TOP MICROBIOL, V183, P1
[15]   NEUTRALIZATION OF PRIMARY HIV-1 ISOLATES BY ANTI-ENVELOPE MONOCLONAL-ANTIBODIES [J].
DSOUZA, MP ;
MILMAN, G ;
BRADAC, JA ;
MCPHEE, D ;
HANSON, CV ;
HENDRY, RM ;
CORCORAN, T ;
STOTT, J ;
FUNG, M ;
HANSON, C ;
LAMAN, J ;
MASCOLA, J ;
MCPHEE, D ;
RASHEED, S ;
RICHMAN, D ;
SCHUITEMAKER, H ;
THIRIART, C ;
WAINBERG, M ;
WEBER, J ;
BEDDOWS, S ;
TILLEY, S ;
ROBINSON, J ;
ZOLLAPAZNER, S ;
KATINGER, H ;
CUMMINS, L .
AIDS, 1995, 9 (08) :867-874
[16]  
FRANCO L, 1994, SCIENCE, V266, P801
[17]   MEETING REPORT - NEUTRALIZATION OF HIV-1 [J].
GOLDING, H ;
DSOUZA, MP ;
BRADAC, J ;
MATHIESON, B ;
FAST, P .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (06) :633-643
[18]   ANTIBODY TO ADHESION MOLECULE LFA-1 ENHANCES PLASMA NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
GOMEZ, MB ;
HILDRETH, JEK .
JOURNAL OF VIROLOGY, 1995, 69 (08) :4628-4632
[19]   NEUTRALIZATION OF DIVERSE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS BY AN ANTI-V3 HUMAN MONOCLONAL-ANTIBODY [J].
GORNY, MK ;
CONLEY, AJ ;
KARWOWSKA, S ;
BUCHBINDER, A ;
XU, JY ;
EMINI, EA ;
KOENIG, S ;
ZOLLAPAZNER, S .
JOURNAL OF VIROLOGY, 1992, 66 (12) :7538-7542
[20]  
GORNY MK, 1993, J IMMUNOL, V150, P635